From July 11st through July 14th, China National Pharmaceutical Industry Information Center （PHIIC）hosted the 32nd PHIIC Annual Conference in Chengdu. PHIIC released the list of China Top 100 Pharmaceutical Companies for 2014. China Grand Enterprises (“CGE”) again made to the list and was ranked the 15th on the list. 

According to PHIIC, the China Top 100 Pharmaceutical Companies List is an annual rank of the top 100 largest Chinese pharmaceutical companies by sales revenue. Over 500 candidates competed for the Top 100 spots in 2014. Eligibility criteria were higher than those of 2013, an indication that pharmaceutical industry is steadily growing in China. 

Pharmaceutical and healthcare sector is among the most important ones for CGE. Up to now, CGE has built a comprehensive business model that integrates R&D, manufacture, marketing and distribution into one, has a combination of Western and traditional Chinese medicines, and with a focus on both domestic and global markets. With strong commitment to quality and innovation, this CGE sector will continue to fulfill the mission of “serving the society”.